How is GLP-1 treatment different in Europe compared with the US?

In France, the UK and Belgium, GLP-1 medication sits inside a multidisciplinary framework: a general practitioner, often a dietitian, sometimes a psychologist, and an endocrinologist in severe cases, all involved before you are judged a candidate. In Belgium the first prescription legally has to go through a specialist within that team. Most of the US telehealth market runs the express-prescription model instead: form filled, injection shipped, no structured follow-up, no nutrition plan and no muscle monitoring.

How much protein should you eat on a GLP-1?

European clinicians prescribe a specific figure rather than general advice: a minimum of 1.2 grams of protein per kilogram of body weight per day, tracked and adjusted as you lose weight, alongside resistance training at least twice a week written into the treatment plan rather than suggested as an optional extra.

Is GLP-1 medication only for weight loss?

Not according to European cardiology. The SELECT trial, a large cardiovascular outcome study, found semaglutide reduced the risk of heart attack and stroke even in people only slightly overweight, at a BMI as low as 27, regardless of how much weight they lost. European cardiologists increasingly discuss GLP-1 as a cardiovascular medication first and a weight-loss medication second.

GLP-1 in Europe vs USA: The Price Gap, Explained

Q: How much muscle do you lose on a GLP-1?

Studies show up to 40% of the weight lost on a GLP-1 can be lean muscle mass, particularly without enough protein and resistance training. European specialists call the result sarcopenic obesity: lighter on the scale but metabolically weaker, with a lower resting metabolism and a much higher chance of regaining the weight after stopping.

Q: What is a GLP-1 exit strategy, and why does it matter?

It is the plan for what happens when you stop the medication, whether by choice, because of side effects or because you can no longer afford it. Most people who come off a GLP-1 without lifestyle infrastructure regain the majority of their weight within 12 months. European endocrinologists raise that question at the first appointment and build the exit into the entry; in the US the conversation rarely happens until it is already a problem.

The short version

Europe treats GLP-1 as a multidisciplinary program (GP, dietitian, sometimes a psychologist) rather than an express prescription.
European clinicians actively monitor muscle loss and discuss an exit strategy on day one, two things most US telehealth skips.
The reframe from European cardiology: GLP-1 is metabolic and cardiovascular care, not just weight loss.
A few US platforms already work the European way: full protocol, muscle preservation, structured follow-up.

40% Of weight lost that can be lean muscle

1.2g Protein per kg of body weight, daily minimum

2× Resistance sessions per week, prescribed

BMI 27 Where SELECT found cardiovascular benefit

The multidisciplinary approach

In France, the UK and Belgium, GLP-1 medications like Wegovy and Mounjaro are tied to a multidisciplinary framework: a general practitioner, often a dietitian, sometimes a psychologist, and in severe cases an endocrinologist, all involved before deciding you're even a candidate. In Belgium, the law requires the first prescription to go through a specialist within that team framework. The majority of the US market, meanwhile, still runs on the express-prescription model: injection shipped, no structured follow-up, no nutrition plan, no muscle monitoring.

What Europeans watch that US telehealth ignores: muscle loss

When you lose weight rapidly on a GLP-1, you're not just losing fat. Studies show up to 40% of the weight lost can be lean muscle mass, especially without enough protein and resistance training. European specialists call the result sarcopenic obesity: lighter on the scale, metabolically weaker. Your resting metabolism drops, and the risk of regaining everything the moment you stop goes through the roof.

What European doctors prescribe alongside the injection:

A protein target: minimum 1.2 g of protein per kg of body weight per day. A specific number, tracked and adjusted, not "eat healthy".
Resistance training at least twice a week, part of the treatment protocol and not optional.

The European protocol

A care team decides you're a candidate first
A tracked protein target, in grams
Resistance training written into the treatment
Behavioral support alongside the injection
The exit plan discussed on day one

The express-prescription model

Form filled, injection shipped
No nutrition plan attached
No muscle monitoring at all
Nothing addressing what food was doing for you
No conversation about stopping, ever

The exit strategy, discussed on day one

European endocrinologists are trained to ask: what's your plan if you can't afford this medication in two years? The data is clear: most people who stop GLP-1 without lifestyle infrastructure regain the majority of their weight within 12 months. European doctors build the exit into the entry. In the US, that conversation almost never happens at the start.

The psychological component

In the UK's NHS pathways and French hospital programs, behavioral therapy is integrated into obesity treatment, not because patients are weak, but because GLP-1 changes your relationship with food at a neurological level. It reduces food noise, yes; it also removes a coping mechanism. If you don't address what food was doing for you emotionally, the habits come back the moment the drug is out of your system.

European doctors build the exit into the entry. In the US, that conversation almost never happens at the start.

The reframe coming from European cardiology

The SELECT trial, a massive cardiovascular outcome study, showed that semaglutide reduces the risk of heart attack and stroke even in people only slightly overweight (BMI as low as 27), regardless of how much weight they lose. European cardiologists now discuss GLP-1 as a cardiovascular drug first, a weight-loss drug second. That reframe is enormous: it's about keeping your heart alive longer.

And a warning: counterfeits

European regulators have been far more aggressive about fake GLP-1 products sold online: the European Medicines Agency flagged it as a priority and multiple countries have seized illegal injectables sold through social media. In the US, people buy these every day without knowing what's in the vial. Rule of thumb: no doctor involved, impossibly low price → walk away. Our legal savings levers get you a low price the safe way.

The US platforms that already work the European way

Not every American platform runs the express model. The one that goes furthest toward the European standard is our #1, Hume Care Plus: weekly body scans that track fat loss versus muscle, a protocol that includes muscle-preservation supplements, and a dedicated doctor available 24/7, exactly the follow-up infrastructure European clinics consider non-negotiable. Enhance MD follows the same philosophy with baseline labs before any prescription and a maintenance (microdosing) strategy for the exit phase.

So what should you actually do?

You cannot import the French healthcare system, and you do not need to. Almost everything described above is a question you can ask before you hand over a card, and the answers separate a care program from a fulfilment service in about four minutes. Take this list to whichever platform you are considering.

Ask before you sign up	What a European-standard answer sounds like
How will you track muscle, not just weight?	Body composition scans, or at minimum a bioimpedance reading and a strength check at each review
What is my protein target, in grams?	A number derived from your body weight, starting around 1.2 g/kg, revisited as you lose
What does the training side of the plan look like?	Resistance work at least twice a week, written into the protocol rather than mentioned in an email
What happens when I stop?	A maintenance or tapering plan discussed now, not eighteen months from now
Who do I talk to when something feels off?	A named clinician reachable between appointments, not a shared support inbox

A platform that answers all five without hedging is running the European model whether it calls it that or not. A platform that cannot answer the first one is selling you a delivery service with a doctor's signature attached, and the muscle you lose on it will not show up on the scale until it is a problem.

Want the European standard of care, US-side? Check your eligibility on Hume Care Plus: free 1-minute assessment, muscle-first protocol, 24/7 medical follow-up.

Medical disclaimer: this article is informational, not medical advice. GLP-1 therapy is prescription treatment, so always consult a licensed healthcare provider.